Lee Ainslie - Maverick Capital
Holding/activity history for Pacira BioSciences Inc. (PCRX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2023 Q3 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2023 Q2 | 5,823 | 0.00 | Buy | 0.00 | $40.01 |
| 2021 Q3 | 0 | 0 | Sell 100.00% | 0.00 | |
| 2021 Q2 | 1,108 | 0.00 | Buy | 0.00 | $60.47 |
| 2020 Q2 | 0 | 0 | Sell 100.00% | 0.03 | |
| 2020 Q1 | 48,159 | 0.03 | Reduce 52.42% | 0.03 | $33.53 |
| 2019 Q4 | 101,219 | 0.07 | Reduce 41.28% | 0.05 | $45.30 |
| 2019 Q3 | 172,380 | 0.10 | Buy | 0.10 | $38.07 |
| 2016 Q2 | 0 | 0 | Sell 100.00% | 1.35 | |
| 2016 Q1 | 1,610,932 | 1.35 | Buy | 1.35 | $52.98 |